Skip to content

Comparing Pleth Variability Index (PVI) Measurements at Different Sensing Locations

Comparing PVI Measurements at Different Sensing Locations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02124551
Enrollment
35
Registered
2014-04-28
Start date
2014-04-30
Completion date
2017-07-31
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Imbalance

Keywords

Goal-directed fluid therapy

Brief summary

The purpose of this study is to assess the suitability of the ear and forehead as a better site for measure of fluid responsiveness.

Detailed description

The aim of this study is to compare Pleth Variability Index (PVI) measurements at different sensor locations in respect to signal quality, sensor fit to site location and fluid responsiveness. PVI will be measured at 3 different sensor sites: the fingers, ear lobes and forehead. The ability to predict fluid responsiveness will be analyzed using cardiac output as the reference value.

Interventions

None listed

Sponsors

Masimo Corporation
CollaboratorINDUSTRY
University of California, Irvine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Undergo any type of surgeries under general anesthesia in UCI Medical Center * Mechanically ventilated during surgery * Arterial line placement is preferred but not required * Agree to sign the consent and HIPAA forms

Exclusion criteria

* Less than 18 years of age * Pregnant women * Refused to sign the consent and HIPAA forms * Receive vasoactive medication prior to surgery * Has these conditions: hypotension, hypothyroidism, moderate or poorly controlled hypertension, chronic poorly-controlled diabetes, heart failure patients, and patients with active airway flow obstruction, left ventricular dysfunction, intra-cardiac shunts, right ventricular dysfunction, atrial fibrillation, arrhythmias * patients with surgeries at or around site of sensor placement * Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails that would prevent monitoring of SpO2 levels during the study

Design outcomes

Primary

MeasureTime frameDescription
PVI measurement of fluid responsivenessIntra-operativeThe primary outcome is to test the ability of PVI recorded at the finger and at the ear to predict fluid responsiveness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026